Author Michael Pollan returns for a discussion on the most intriguing questions at the intersection of psychedelics and consciousness.

Could you reopen your childhood brain? Neil deGrasse Tyson, Chuck Nice, & Gary O'Reilly explore what a high octopus can teach us about the brain w/ Gül Dölen

👁️ Is what you're seeing right now real, or a very convincing hallucination your brain is constructing? The camera is a common metaphor for human vision. In…

Author Michael Pollan returns for a discussion on the most intriguing questions at the intersection of psychedelics and consciousness.

Even for experienced researchers, working with psychedelics can pose new challenges, from procuring Schedule I substances to guiding participants through potential psychoactive effects to documenting ...

Could psychedelic therapy cure phantom limb pain? Amputee Miles O'Brien joins a trial testing if psychedelics can rewire the brain's pain circuits.

Lawler discusses new archeological tools for studying psychoactive plant residues.

Plus: New Mexico program licenses first producer, and an opinion on why taking the trip out of psychedelic medicine is a mistake

We’re bringing you the highlights from today’s four hour-long hearing, held by the U.S.

Plus: Ketamine seized at the UK border hits record high; an Arizona ibogaine trial; Study reveals cell signaling that differentiates hallucinogens and non-hallucinogens

Herzberg discusses the history of “mind medicines” like Prozac and parallels between antidepressants and psychedelics.

How the conservative activist Bryan Hubbard, with help from Rick Perry and Joe Rogan, persuaded Trump and the G.O.P. to embrace ibogaine, a psychedelic drug derived from an African shrub.

Institute of Personality and Social Research Colloquium Psychedelics are a broad category of compounds that induce altered states of consciousness...

Plus: Pharmaceutical giant Eli Lilly makes a psychedelics acquisition; Cardiovascular safety is top of mind for psychedelics researchers

Author Michael Pollan returns for a discussion on the most intriguing questions at the intersection of psychedelics and consciousness.

Author Michael Pollan returns for a discussion on the most intriguing questions at the intersection of psychedelics and consciousness.

Ham discusses doing interviews with clinical trial participants who didn't experience substantial benefits.

npj Mental Health Research - Well-being as a primary endpoint in clinical trials: a call for consensus

Author Michael Pollan returns for a discussion on the most intriguing questions at the intersection of psychedelics and consciousness.

Hashemi discusses her approach to drug education and what students want to know about psychedelics.

Romero discusses what a recently discovered manuscript reveals about peyote in the 17th century.

Romero discusses what a recently discovered manuscript reveals about peyote in the 17th century.

Dupuis discusses how auditory hallucinations during psychedelic trips have been overlooked.

Plus: Compass Pathways announces new Phase 3 results, and Lawsuit against LSD company Definium is dismissed

Plus: Survey suggests most veterans support VA-funded psychedelic-assisted therapy, and psychedelic research funding bills and a move towards psilocybin legalization in Canada

Plus: Scientists assess risk of psychedelic-induced mania; and the close of this season’s psychedelic legislation push

Can psychedelics help our minds and brains stay healthy as we grow older? That’s the question posed by a new first-of-its-kind study launched earlier this year at the UC Berkeley Center for the Scienc...